AURA: Wutah pendapatan triwulanan Aura Biosciences, Inc.

Logo perusahaan publik Aura Biosciences (AURA)

Aura Biosciences, Inc. (AURA) focuses on developing targeted therapies for eye and bladder cancer using virus-like particles. The business is fully insulated from macroeconomic shocks and inflationary risks. The implementation of automated laboratories significantly accelerates the discovery of new molecules. The company's quarterly revenue growth demonstrates current development dynamics, where 0.00 is the current value of the indicator.

Aura Biosciences Inc (AURA) - Tambahing pendapatan triwulanan saka 04.07.2022 nganti 22.11.2026

Rincian metrik lan analitis perusahaan Aura Biosciences Inc (AURA)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:AURA - aurabiosciences.com
Produk sing diprodhuksi Aura Biosciences

Investors are assessing fundamental capital risks by analyzing the resilience of cash flows to changes in monetary policy. The high level of academic expertise within the Aura Biosciences, Inc. (AURA) management team in oncobiotech enables the efficient conversion of R&D results into commercial success. The growth dynamics of the company's quarterly revenue measure the actual speed of business expansion, excluding temporary distortions caused by excess liquidity. The steady upward trend of this indicator confirms market recognition of the viral conjugate platform.

Pesaing Aura Biosciences, Inc.

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|candeltx.com - Owah-owahan dodolan kuartal marang kuartal|ARAY: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan Citius Oncology Inc. (CTOR)|Wutah pendapatan kuartal marang kuartal TuHURA (HURA)|TARA - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Tingkat wutah pendapatan sajrone kuartal|TScan - Wutah pendapatan triwulanan|Champions Oncology, Inc. (CSBR) - Wutah dodolan triwulanan|XBIT (XBiotech Inc.) - Wutah dodolan triwulanan|CEL-SCI Corporation (CVM) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal OS Therapies|RADX: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal artivabio.com (ARTV)|Tingkat wutah dodolan sajrone kuartal Adlai Nortye|Wutah pendapatan triwulanan VERU (Veru Corporation)|Owah-owahan dodolan kuartal marang kuartal TPST (Tempest Tx)|XLO: Wutah dodolan triwulanan|renovarobio.com (RENB) - Wutah dodolan triwulanan|Mural Bio (MURA) - Wutah pendapatan kuartal marang kuartal|Kairos Pharma Inc (KAPA) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan OKUR|CytoMed Therapeutics (GDTC) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan CRIS (Curis Inc.)|Wutah pendapatan triwulanan Apollomics Inc. (APLM)|Wutah pendapatan kuartal marang kuartal Tharimmune Corp THAR|Advanced Biomed Corp - Wutah pendapatan kuartal marang kuartal|GNPX: Wutah dodolan triwulanan|Calidi Biotherapeutics, Inc. (CLDI) - Wutah dodolan triwulanan|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)